Oncologists Use Lung Cancer Vaccine to Personalize Care
September 3rd, 2008
University of Cincinnati ( UC ) oncologists are involved in one of the largest international cancer vaccine clinical trials to date aimed at reducing recurrence and improving life expectancy among early-stage lung cancer survivors.Â
Led locally by Apurva Mehta, MD, the phase-3 trial is expected to enroll a total of 2,300 patients through 100 centers in the United States and 400 globally. Mehta is looking for about five local patients who have stage IB through stage IIIA non small-cell lung cancer to participate in the study.
At 5:06 pm on September 6th, 2008 Dr. Leonard said:
What is the vacine made of?